← Leaderboards
Partha Pratim Nag
Broad Institute, Inc.
$451,866
Attributed
$451,866
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $239.4K · FY2019–20$250K$187.5K$125K$62.5K$0
'19
'20
Funding mix
By agency
NIH$451,866 · 1
By mechanism
R21$451,866 · 1
Top collaborators
No co-investigators on record.
Most similar at Broad Institute, Inc.
Same institution · by research overlap
- Christina A Cuomo$14,935,659
- Bruce W. Birren$86,324,836
Others in their field
Other Emerging Leaders on “Clinical Management”
- Leonard Freedman · Leidos Biomedical Research, Inc.$533,250,348
- Bambra Strokes · Ppd Development Lp$526,656,217
- Chanza Baytop · Westat, Inc.$271,217,917
- Lynn Briscoe · Leidos Biomedical Research, Inc.$155,198,391
- Leonard Freedmand · Leidos Biomedical Research, Inc.$98,649,302
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,912,072
Research focus
Clinical ManagementClinical SciencesAnalogAntifungal TherapyAnti-Infective AgentsAnimal ModelAntifungal AgentsBacterial DnaBacterial InfectionsBaseBasic ScienceBiochemicalBiologyAspergillus FumigatusCandida AlbicansAzole ResistanceCandida GlabrataCause Of DeathCharacteristicsChemical StructureChemical SynthesisClinical DevelopmentClinically RelevantClinical Treatment
Grant awards (2)
Discovering novel antifungal agents via multi-species profiling of a structurally and stereochemically diverse, well-validated compound library$212,512
R21 · FY2020 · AI · contact PI
Discovering novel antifungal agents via multi-species profiling of a structurally and stereochemically diverse, well-validated compound library$239,354
R21 · FY2019 · AI · contact PI